- 14.07.2025 - 16:52
Background of the Project
Currently, India’s Health Benefit Packages (HBF) do not sufficiently reflect the cost variation associated with different patient profiles in breast cancer treatment. For example, hospitals receive the same flat-rate payment for breast cancer patients, regardless of key cost drivers such as patient age and co-morbidities, type of surgical intervention, length of hospital stay, complexity of clinical management. This can lead to misaligned incentives and inequities in resource allocation across hospitals.
Our project supports CGD Europe in developing a cost collection and allocation framework that makes these variations visible and quantifiable. This framework may lay the foundation for more refined and cost-homogeneous payment models in India’s future health financing system.
What We Did During the Visit
Over a 3-day workshop in Mumbai, our team worked closely with TMH’s clinical, administrative, and health economics staff. Key highlights included:
In addition to the technical sessions, we were treated to warm hospitality, including local dinners, a guided tour of Mumbai, and cultural exchanges with the TMH team.
Looking Ahead
This visit marks a major step forward in our pilot project and deepened our collaboration with TMH. The insights gained will help shape a scalable, data-informed approach to health benefit design in India—bringing patient complexity and real-world cost drivers into national reimbursement systems.
We thank the entire TMH team for their exceptional hospitality, openness, and commitment to improving cancer care in India.